Our Services
Core Team
Consulting Network
Resources
- Case Studies
- Blog
- News
- Whitepapers
Careers
Contact

Biotech & Pharmaceutical Consulting

business development

These selected case studies illustrate the scope of our work, the level of expertise we’re able to offer, and our consistent record of successful engagements.

why us?
Case Studies
business development

Reality check on a new biosensor technology

Challenge A company considering an investment in a new early-stage biosensor technology for the measurement of blood pressure needed due diligence support. The product had a number of potential...

Providing an oncology cell therapy reality check

Challenge A venture capital investor needed a reality check on a clinical stage cancer biologic prior to a proposed $10m investment.

Due diligence of a small molecule arising from a phenotypic screen

Challenge Our client asked us to conduct a risk assessment and due diligence of a small molecule oncology compound that had been identified from a phenotypic screen. The molecule was in a Phase I/II...

Due diligence and valuation of a preclinical kinase inhibitor

Challenge We were commissioned to conduct a comprehensive technical risk assessment and due diligence of a novel preclinical, small molecule, kinase inhibitor.

Benchmarking products for the diagnostics market

Challenge A major European venture capital investor needed help to review the business plan and competitive positioning of a novel point-of-care diagnostics company. The company was developing a...

Providing due diligence support for a clinical stage, type 1 diabetes immunotherapy project

Challenge A clinical stage, type 1 diabetes immunotherapy project needed convincing partnering materials and advice on data room structure and due diligence preparations.

Providing due diligence on a pain in-licensing opportunity

Challenge A European pharma company needed to conduct an expert reality check on a pain in-licensing opportunity.

Providing due diligence of a novel drug formulation

Challenge An established medical device company looking to make a strategic investment needed commercial, regulatory, IP and technical due diligence on an investment opportunity in the diabetes...

Providing life science reagents due diligence

Challenge A major UK bioscience investor needed due diligence on a cell biology reagents investment opportunity.

Assessing oral delivery of biopharmaceuticals

Challenge An incoming lead investor needed to assess a proprietary platform technology for the oral delivery of biological drugs.

Providing clinical due diligence of a novel biologic to treat respiratory disease

Challenge A pharma company looking to purchase an asset needed a respiratory consultant to conduct clinical due diligence of a Phase II biologic designed to treat a respiratory condition.

Providing Phase lll-ready radiolabelled antibody due diligence

Challenge A well-capitalized strategic investor looking to enter the radiopharmaceuticals market wanted to conduct clinical due diligence on a novel radioisotope-conjugated antibody designed to treat...

1 ... 6 7 8 9 10 ... 12

Content not found

Need biotech consulting support? We can help.

Contact us today to learn how our pharma & biotech consulting expertise can serve your project.

Contact us

Explore our biotech & life science consulting services

Strategy and Commercialization Learn more
Product Development Learn more
Business Development Learn more

© 2023 Alacrita Holdings Limited | Pharma & Biotech Consulting

Privacy Notice

Alacrita Life Science Consulting
2 Royal College St
London, UK
NW1 0NH

Registered in England & Wales.
No. 10530608

One Broadway
Floor 14
Cambridge, MA 02142

Registered in Massachusetts.